Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The EMA has recommended a precautionary recall of one remaining batch of cidofovir [Vistide],

    • 14 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      EMA.European Medicines Agency recommends precautionary recall of remaining batch of Vistide manufactured at Ben Venue Laboratories. Media Release: 13 Dec 2011. Available from: URL: http://www.ema.europa.eu

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    The EMA has recommended a precautionary recall of one remaining batch of cidofovir [Vistide],. React. Wkly. 1383, 2 (2012). https://doi.org/10.2165/00128415-201213830-00003

    Download citation

    Keywords

    • Public Health
    • Retina
    • Quality Assurance
    • Cidofovir
    • Alternative Manufacturer